本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

42.02
-2.9000-6.46%
盘前42.030.0100+0.02%04:25 EDT
成交量:107.74万
成交额:4,587.02万
市值:33.46亿
市盈率:-11.19
高:44.62
开:44.00
低:41.77
收:44.92
数据加载中...
2022/09/16

重要事件披露

8-K - Current report
2022/09/15

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/13

重要事件披露

8-K - Current report
2022/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

重要事件披露

8-K - Current report
2022/06/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/16

重要事件披露

8-K - Current report
2022/06/08

重要事件披露

8-K - Current report
2022/06/03

重要事件披露

8-K - Current report
2022/05/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/06

重要事件披露

8-K - Current report
2022/03/02

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/25

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals